Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

mTOR signaling helps activate hair stem cells by balancing out the suppression caused by BMP during hair growth.

The BMP2 gene is more active in the early growth phase of Cashmere goat hair and may affect hair regeneration and textile production.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Tiny needles with valproic acid can effectively regrow hair.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

Claudin-1 is important for the barrier function and growth of hair.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Bimatoprost eye drops can increase eyelash length and strength.

Coat-type differences in Pomeranians affect Alopecia X diagnosis and treatment.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Sandalore® reduces hair shedding and increases hair volume in women with telogen effluvium.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

PRP injections may help treat hair loss.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Autophagy helps activate hair stem cells and hair growth by changing their energy use to glycolysis.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Pomegranate leaf extract may help with hair growth, dandruff, and lice.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.